Halozyme Therapeutics Inc. (0J2O)
Market Closed
16 Oct, 03:30 PM
$
120. 99
-0.34
-0.2834%
$
- Market Cap
20.87 P/E Ratio
- Div Yield
1,591 Volume
2.74 Eps
$ 121.33
Previous Close Want to track 0J2O and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Halozyme Therapeutics Inc. (0J2O) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.81B
Trailing P/E (ttm) 34.61
Forward P/E -
PEG ratio -1.62
Price/Sales (ttm) 8.31
Price/Book (mrq) 99.54
Enterprise Value/Revenue 9.5
Enterprise Value/EBITDA 22.01
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.89K
Average volume (90 days) 1.03K
Price summary
52-Week low 59.85
52-Week high 122.72
Beta -
50-Day moving average 110.83
200-Day moving average 85.01
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 171:40
Last split Date 10 Dec 2003
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.25%
Operating margin 0.56%
Operational effectiveness
Return on assets 0.16%
Return on equity 1.81%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.19
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.97
Total debt (mrq) -
Total Debt/Equity (mrq) 14.95
Current ratio (mrq) 2.71%
Book value per share (mrq) 1.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
